Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Purchase | 2024-11-19 7:59 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $7.727 | $38,635 | 65,429 (Direct) | View |
| 2023-10-12 Purchase | 2023-10-12 5:09 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $8.37 | $41,850 | 19,429 (Direct) | View |
| 2021-12-27 Sale | 2021-12-28 8:58 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $46.45 | $232,250 | 14,429 (Direct) | View |
| 2021-06-16 Purchase | 2021-06-16 6:46 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $26.09 | $130,447 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-08 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 163,200 | $0 | 163,200 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:21 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 41,000 | $0 | 60,429 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:53 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-14 8:00 pm | N/A 2032-03-11 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-10-11 Exercise | 2021-10-12 8:02 pm | N/A 2030-06-18 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 14,429 | $0 | 61,817 (Direct) | View |
| 2021-10-11 Exercise | 2021-10-12 8:02 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 14,429 | $6.16 | 61,817 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 8:00 pm | N/A 2031-06-24 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:15 pm | N/A 2031-03-01 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 72,000 | $0 | 72,000 (Direct) | View |
Ownership | 2020-07-23 7:27 pm | N/A 2030-06-18 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 0 | $0 | 317,076 (Direct) | View |